Fermentation Facility News | CSL Behring Fermentation Facility

Oct 23, 2019

CSL Behring honored as Penn State’s Corporate Partner of the Year

Penn State has named global biotech leader CSL Behring as its 2019 Corporate Partner of the Year. The University presented the award to corporate representatives at a luncheon today (Oct. 18).

Full Article

May 24, 2019

First Annual Seed Grant Recipients Announced by the Center of Excellence in Industrial Biotechnology

Seed Grant funding allows faculty at Penn State to initiate research in novel areas of biotechnology.

Full Article

Paul Perreault, CEO and managing director of CSL Limited, was the guest speaker at the March 12 Penn State Forum. IMAGE: PATRICK MANSELL

Mar 13, 2019

Heard on Campus: Paul Perreault at the Penn State Forum

Paul Perreault, chief executive officer and managing director of CSL Limited, the second largest biotherapeutics company in the world with more than 22,000 employees, presented “Innovation in Biotechnology: The Promise, The Potential, The Pitfalls” at the Penn State Forum on March 12 at The Nittany Lion Inn.

Full Article

Nov 06, 2018

Partnership announced between Commonwealth Campuses and shared facilities

The Office of the Vice President for Research at Penn State has announced the launch of a new program to support increased usage of shared core facilities and services by faculty at the Commonwealth Campuses.

Full Article

Aug 30, 2018

New Fermentation Facility Brings New Opportunities

With a generous gift from its namesake benefactor, the CSL Behring Fermentation Facility puts Penn State students a step ahead

Full Article

Jan 21, 2014

Announcing major equipment acquisitions at the Huck Institutes

The Huck Institutes of the Life Sciences, in conjunction with the Office of the Vice President for Research and the Office of the Provost, are pleased to announce several major equipment acquisitions that will further strengthen the research capabilities of their Core Facilities at University Park.

Full Article

Aug 03, 2010

Ancient gene family linked to the future of epileptic seizures

A potassium-channel gene belonging to an ancient gene family more than 542 million years old is opening new avenues in epilepsy research, and may one day allow researchers to develop more effective drugs with fewer side effects for the treatment of epileptic seizures.

Full Article